3-(S)-amino-piperidine pyridyl carboxamide (LGB321), a selective small-molecule pan-PIM kinase inhibitor, significantly decreased the mTORC1 activity to inhibit MM cell proliferation [139]. Here, PIM1 is linked to Miyoshi myopathy.